Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpo... von Foster, Corey C., Couey, Marcus A., Kochanny, Sara E., Khattri, Arun, Acharya, Rajesh K., Tan, Yi‐Hung Carol, Brisson, Ryan J., Leidner, Rom S., Seiwert, Tanguy Y.

Volltext

Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL von Tan, Yi-Hung Carol, Mirzapoiazova, Tamara, Won, Brian M., Zhu, Li, Srivastava, Minu K., Vokes, Everett E., Husain, Aliya N., Batra, Surinder K., Sharma, Sherven, Salgia, Ravi

Volltext

CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases von Tan, Yi-Hung Carol, Krishnaswamy, Soundararajan, Nandi, Suvobroto, Kanteti, Rajani, Vora, Sapana, Onel, Kenan, Hasina, Rifat, Lo, Fang-Yi, El-Hashani, Essam, Cervantes, Gustavo, Robinson, Matthew, Hsu, Han-Shui, Kales, Stephen C, Lipkowitz, Stanley, Karrison, Theodore, Sattler, Martin, Vokes, Everett E, Wang, Yi-Ching, Salgia, Ravi

Volltext

Novel EPHB4 Receptor Tyrosine Kinase Mutations and Kinomic Pathway Analysis in Lung Cancer von Ferguson, Benjamin D., Carol Tan, Yi-Hung, Kanteti, Rajani S., Liu, Ren, Gayed, Matthew J., Vokes, Everett E., Ferguson, Mark K., John Iafrate, A., Gill, Parkash S., Salgia, Ravi

Volltext

A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer von Tang, Yen-An, Wen, Wei-Ling, Chang, Jer-Wei, Wei, Tzi-Tang, Tan, Yi-Hung Carol, Salunke, Santosh, Chen, Chien-Tien, Chen, Ching-Shih, Wang, Yi-Ching

Volltext

Differential expression of RON in small and non-small cell lung cancers von Kanteti, Rajani, Krishnaswamy, Soundararajan, Catenacci, Daniel, Tan, Yi-Hung Carol, EL-Hashani, Essam, Cervantes, Gustavo, Husain, Aliya N., Tretiakova, Maria, Vokes, Everett E., Huet, Heather, Salgia, Ravi

Volltext

Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines von Mirzapoiazova, Tamara, Pozhitkov, Alexander, Nam, Arin, Mambetsariev, Isa, Nelson, Michael, Tan, Yi‑Hung, Zhang, Keqiang, Raz, Dan, Singhal, Sharad, Nasser, Mohd, Kulkarni, Prakash, Batra, Surinder, Sattler, Martin, Salgia, Ravi

Volltext

Inhibiting crosstalk between MET signaling and mitochondrial dynamics and morphology: a novel therapeutic approach for lung cancer and mesothelioma von Wang, Jiale, Mirzapoiazova, Tamara, Carol Tan, Yi-Hung, Pang, Ka Ming, Pozhitkov, Alex, Wang, Yingyu, Wang, Yang, Mambetsariev, Bolot, Wang, Edward, Nasser, Mohd W., Batra, Surinder K., Raz, Dan, Reckamp, Karen, Kulkarni, Prakash, Zheng, Yanfang, Salgia, Ravi

Volltext

The Role of Immunotherapy in Extensive Stage Small-Cell Lung Cancer: A Review of the Literature von Tsiouprou, Ioanna, Spyratos, Dionisios, Zaharias, Athanasios

Volltext

The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target von Ferguson, Benjamin D, Liu, Ren, Rolle, Cleo E, Tan, Yi-Hung Carol, Krasnoperov, Valery, Kanteti, Rajani, Tretiakova, Maria S, Cervantes, Gustavo M, Hasina, Rifat, Hseu, Robyn D, Iafrate, A John, Karrison, Theodore, Ferguson, Mark K, Husain, Aliya N, Faoro, Leonardo, Vokes, Everett E, Gill, Parkash S, Salgia, Ravi

Volltext

EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma von Tan, Yi-Hung Carol, Srivastava, Saumya, Won, Brian M., Kanteti, Rajani, Arif, Qudsia, Husain, Aliya N., Li, Hubert, Vigneswaran, Wickii T., Pang, Ka-Ming, Kulkarni, Prakash, Sattler, Martin, Vaidehi, Nagarajan, Mambetsariev, Isa, Kindler, Hedy L., Wheeler, Deric L., Salgia, Ravi

Volltext

An E3 Ubiquitin Ligase: c-Cbl: A New Therapeutic Target of Lung Cancer von LO, Fang-Yi, CAROL TAN, Yi-Hung, CHENG, Hung-Chi, SALGIA, Ravi, WANG, Yi-Ching

Volltext

An E3 ubiquitin ligase: c‐Cbl von Lo, Fang‐Yi, Tan, Yi‐Hung Carol, Cheng, Hung‐Chi, Salgia, Ravi, Wang, Yi‐Ching

Volltext

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigatio... von Vigneswaran, Janani, Tan, Yi-Hung Carol, Murgu, Septimiu D, Won, Brian M, Patton, Kathryn Alexa, Villaflor, Victoria M, Hoffman, Philip C, Hensing, Thomas, Hogarth, D Kyle, Malik, Renuka, MacMahon, Heber, Mueller, Jeffrey, Simon, Cassie A, Vigneswaran, Wickii T, Wigfield, Christopher H, Ferguson, Mark K, Husain, Aliya N, Vokes, Everett E, Salgia, Ravi

Volltext

Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma von Rolle, Cleo E, Tan, Yi-Hung Carol, Seiwert, Tanguy Y, Vora, Sapana, Kanteti, Rajani, Hasina, Rifat, Carey, George B, Surati, Mosmi, Weichselbaum, Ralph R, Lingen, Mark W, Vokes, Everett E, Salgia, Ravi

Volltext

The Chicago Thoracic Oncology Database Consortium: A Multisite Database Initiative von Won, Brian, Carey, George B, Tan, Yi-Hung Carol, Bokhary, Ujala, Itkonen, Michelle, Szeto, Kyle, Wallace, James, Campbell, Nicholas, Hensing, Thomas, Salgia, Ravi

Volltext

Correction: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases von Tan, Yi-Hung Carol, Krishnaswamy, Soundararajan, Nandi, Suvobroto, Kanteti, Rajani, Vora, Sapana, Onel, Kenan, Hasina, Rifat, Lo, Fang-Yi, El-Hashani, Essam, Cervantes, Gustavo, Robinson, Matthew, Hsu, Han-Shui, Kales, Stephen C., Lipkowitz, Stanley, Karrison, Theodore, Sattler, Martin, Vokes, Everett E., Wang, Yi-Ching, Salgia, Ravi

Volltext

A pan-cancer organoid platform for precision medicine von Larsen, Brian M., Kannan, Madhavi, Langer, Lee F., Leibowitz, Benjamin D., Bentaieb, Aicha, Cancino, Andrea, Dolgalev, Igor, Drummond, Bridgette E., Dry, Jonathan R., Ho, Chi-Sing, Khullar, Gaurav, Krantz, Benjamin A., Mapes, Brandon, McKinnon, Kelly E., Metti, Jessica, Perera, Jason F., Rand, Tim A., Sanchez-Freire, Veronica, Shaxted, Jenna M., Stein, Michelle M., Streit, Michael A., Tan, Yi-Hung Carol, Zhang, Yilin, Zhao, Ende, Venkataraman, Jagadish, Stumpe, Martin C., Borgia, Jeffrey A., Masood, Ashiq, Catenacci, Daniel V.T., Mathews, Jeremy V., Gursel, Demirkan B., Wei, Jian-Jun, Welling, Theodore H., Simeone, Diane M., White, Kevin P., Khan, Aly A., Igartua, Catherine, Salahudeen, Ameen A.

Volltext

Phase II trial of pembrolizumab (P) in patients (pts) with previously-treated mesothelioma (MM) von Desai, Arpita, Karrison, Theodore, Rose, Buerkley, Pemberton, Erika, Hill, Bianca, Straus, Christopher M., Tan, Yi-Hung Carol, Seiwert, Tanguy Y., Kindler, Hedy L.

Volltext

Mechanism of acquired resistance to cetuximab in head and neck cancer von Khattri, Arun, Sheikh, Nizamuddin, Acharya, Rajesh, Tan, Yi-Hung Carol, Kochanny, Sara, Lingen, Mark W., Vokes, Everett E., Seiwert, Tanguy Y.

Volltext